Contract development and manufacturing organization SpectronRx announced it has received a materials license from the U.S. Nuclear Regulatory Commission to expand its new facility in Indianapolis.
The materials license authorizes SpectronRx to receive, acquire, possess, and transfer byproduct, source, and special nuclear material in chemical and/or physical form at its new 60,000-sq-ft facility in Indianapolis. The company now has two facilities in Indiana. It opened a 6,300-sq-ft facility in South Bend in 2016.
The company stated in a release that it has plans to expand into the European Union.
